Digital Health and Health Tech Podcasts

Most of us have already heard about blockchain technology, as well as many things about cryptocurrencies and how they are transforming traditional approaches in the field of finance. But what about its relevance to healthcare and the potential applications it may have in this space? Eberhard Scheuer is the President of the dHealth Foundation, a not-for-profit organization from Switzerland providing the infrastructure and tools to major stakeholders in healthcare to leverage blockchain technology. He takes us through the basic concepts around blockchain and guides us through the benefits and the applications it may have in this field, when it comes for instance to empowering patients in managing their own health and the data that accompanies it, creating transparency across the pharmaceutical supply chain, or even preserving the authenticity of medical test results! A fascinating exchange and good entry point for newcomers in the field of blockchain and web3 applied to healthcare! Timeline: 02:21 - Eberhard’s background and his entry point in web3 concepts applied to healthcare 06:29 - What blockchain is about 11:12 - Applications of blockchain technology to healthcare and its benefits 21:51 - The example of Estonia with blockchain-enabled electronic health records and the efforts of big tech companies in that regard 25:58 - The reason behind the dHealth Foundation and monetizing health data 38:30 - The services provided by the dHealth Foundation to its partners 46:44 - Misleading ideas around blockchain applications in healthcare What we also talked about with Eberhard Bitcoin Ethereum The Swiss Tropical and Public Health Institute Roche Digital twin Alex Cahana If you want to know more about the dHealth Foundation, we invite you to consult their website and follow their activities on LinkedIn, Medium and Twitter. As mentioned by Eberhard in the episode, if you want to know more about the field of blockchain and the latest trends in that regard, have a look at Blockchain Revolution, Bloomberg Crypto, CoinDesk and Cointelegraph. You can get in touch with Eberhard through LinkedIn or by email: [email protected] If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or by email: [email protected] And if you liked the episode, don’t hesitate to share it, subscribe to the podcast and leave a positive review on streaming platforms! You can follow our activities through our website, over LinkedIn, or on Instagram!

To discover the whole episode type “#10 - Applying blockchain technology to the healthcare sector - Eberhard Scheuer - dHealth Foundation" on your streaming platform.

In this episode you will learn how technology can help people prevent chronic disease and start building healthier lifestyles that can affect policies from the ground up.

This is the second episode in a special series about cancer, cancer care, accessibility and technologies related to cancer care. The first episode focused on the current state of cancer care with a speaker from Canada - David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Oncology at the University of Ottawa and The Ottawa Hospital. David explained the current state of cancer care, IT in oncology and financial toxicity of a cancer diagnosis for patients.  This, second episode, dives into genomics, the role of AI, and data science in oncology. Speaker: Xose M. Fernandez, genomicist and up until recently the Chief Data Officer at Institut Curie in France, one of the leading medical, biological, and biophysical research centers in the world.   SUBSCRIBE TO THE MONTHLY NEWSLETTER: https://fodh.substack.com/ www.facesofdigitalhealth.com Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth Thank you! :)

Healthcare IT organizations have weathered numerous storms over the past two years—and the lessons these teams learned while on the forefront of the pandemic are shaping their approaches looking ahead. Automation initiatives and the resulting workforce transformation are delivering real-world operational efficiencies while improving the patient experience. Hear Dr. Yan Chow, Global Healthcare Leader at Automation Anywhere and Marcus Johnson, Managing Director of Delivery at Lumevity, Highmark Health’s transformation specialist, discuss how automation has and is improving key aspects of the business.

HHS data reported that breaches of healthcare facilities rose 55% in 2020, with nearly 1 million patients affected monthly.

Know Stroke Podcast Ep 34 -Spotlight on Afib Awareness September is Afib Awareness Month. Atrial fibrillation (Afib) is the most common irregular heartbeat and is characterized by heart palpitations, dizziness, and shortness of breath. Afib is sometimes silent and may not exhibit symptoms at all yet it increases stroke risk and can lead to heart failure, kidney problems and dementia. It can also increase your risk of death so early detection and treatment is critical to reduce risk. About our Guest: On today’s show we were joined by James Amihood, CEO of Cardiokol Cardiokol is a privately-owned digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations. James has 25 years of management experience including CEO of PRM Inc., GM of Syqe Medical and senior positions at multinational pharmaceutical and healthcare companies (Teva, Schering Plough, Perrigo), managing subsidiaries and heading BD and M&A. He holds BSc in Chemistry, BSc IE, MBA Learn more here:  https://www.cardiokol.com/ Today’s Show Resources: Afib Awareness Resource https://www.stopafib.org Apple Watch Study https://www.fiercehealthcare.com/digital-health/nih-funded-study-test-if-apple-watch-can-prevent-strokes-limit-blood-thinners Show Info: Music intro credit to Jake Dansereau, connect at JAKEEZo on Soundcloud @user-257386777.  Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast. Thank you Caroline! Until next time, be sure to give the show a like and share, +follow and connect with us on social or contact us to be a guest on the Know Stroke Podcast https://www.know-stroke.org

Have you ever wondered how clinical trials have changed over time? In this episode, you will discover how artificial intelligence is used in clinical trials, specifically in participant recruitment and protocol design.

Starting in 2023, Medicare Part B premiums are set to decrease for most beneficiaries. While this may seem like good news at first glance, it's important to understand why the premiums are decreasing.On this episode of CareTalk, John and David explore the reasons why Medicare Part B premiums will drop in 2023.TOPICS:(0:36) With the cost of life going up, how much are premiums going up in Medicare?(1:00) Why are the Medicare Part B premiums dropping in 2023?(1:48) What does Aduhelm have to do with premiums dropping?(3:17) What ever happened to Aduhelm?(3:52) How does Medicare work?(6:26) Is the drop in Medicare Part B premiums good news?(9:41) How much will the Medicare Part B premiums decrease? (13:47) How will the changes in Medicare premiums affect the mid-term elections?  ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare system. Join co-hosts John Driscoll (CEO, CareCentrix) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHBecome a CareTalk Podcast sponsor: https://www.caretalkpodcast.com/work-with-us Guest appearance requests: https://www.caretalkpodcast.com/contact-us Visit us at https://www.caretalkpodcast.comFOLLOW CARETALK Spotify Apple Podcasts Google Podcasts Follow John on Twitter Follow David on Twitter#healthcarepodcast #healthcareindustry #healthcarebusiness #healthcarepolicy #ushealthcare #medicare #medicarepartb #healthinsurance #aduhelm #medicine

ONCE UPON A GENE - EPISODE 154 A Groundbreaking Gene Therapy In Record Time to Cure His Son with SPG50 Sets a New Course For Future Rare Disease Treatments with Terry Pirovalakis Terry Pirovolakis is a rare disease crusader and father to Michael, who has SPG50. He made a gene therapy for his son in only 18 months. The work he has done will also transform the way rare diseases are treated. He's hosting free monthly 101, 102 and 103 gene therapy courses to help other families advance their programs. Learn more by visiting Terry's website, cureSPG50.org or by connecting with him on social media. EPISODE HIGHLIGHTS Can you share a little bit about Michael's diagnosis? Michael was born healthy, but wasn't hitting milestones like my other children. We learned through testing that he had a disease called Spastic Paraplegia Type 50 (SPG50). Shortly after the diagnosis, we began researching and reading articles, we flew to meet with experts in gene therapy and signed a contract a month later to start a gene therapy program which kicked off our journey. Is there a point where it's too late for gene therapy? I don't think it's ever too late for gene therapy. My perspective is that if children can get it from 1-6 months old, gene therapy can be a cure. After that, gene therapy becomes less of a cure and more of a treatment. Unfortunately for Michael, gene therapy is a treatment and not a cure, but our goal is to cure kids by getting SPG50 on the newborn screening panel so we can cure kids- not treat them.  What is your advice for other families who are on a journey to fund gene therapy and drug development? Families have to understand that a lot of money has to be raised and they have to be willing to give up a lot to get the money you need. You have to have a solid family and the right team. Get your community involved, get friends and family involved and think outside the box to spread awareness about your disease. I encourage families to take my classes and reach out to me throughout the gene therapy and drug development journey. CONNECT WITH TERRY Website https://www.curespg50.org/ Facebook https://www.facebook.com/CureSPG50 Instagram https://www.instagram.com/cure_spg50/ Twitter https://twitter.com/CureSPG50 Email [email protected] TUNE INTO THE ONCE UPON A GENE PODCAST Spotify https://open.spotify.com/show/5Htr9lt5vXGG3ac6enxLQ7 Apple Podcasts https://podcasts.apple.com/us/podcast/once-upon-a-gene/id1485249347 Stitcher https://www.stitcher.com/podcast/once-upon-a-gene Overcast https://overcast.fm/itunes1485249347/once-upon-a-gene CONNECT WITH EFFIE PARKS Website https://effieparks.com/ Twitter https://twitter.com/OnceUponAGene Instagram https://www.instagram.com/onceuponagene.podcast/?hl=en Built Ford Tough Facebook Group https://www.facebook.com/groups/1877643259173346/ Once Upon a Gene TV https://www.thedisordercollection.com/

Meet Keith Pitts:Keith Pitts is the Operating Advisor for Clayton Dubilier and Rice. Previously, he was the Vice Chairman of Tenet Healthcare Corporation and the Vice Chairman of Vanguard Health Systems. Prior to Vanguard Health Systems, Keith served as the Chairman and CEO of Mariner Post-Acute Network as well as the Executive Vice President and CFO for OrNda HealthCorp. He received a Bachelor’s in Business Administration from the University of Florida.  Key Insights:Change in healthcare is evolutionary, not revolutionary. Keith Pitts explores the progression of healthcare from the 90s to today, and provides insights to where the industry is headed next. Healthcare Evolution. Consumers have changed their healthcare preferences. More than ever, patients accept virtual care and receiving health in non-hospital environments, such as at-home care. Keith predicts there will be a trend towards the “de-institutionalization” of low-acuity care.Government’s Role in Healthcare. The U.S. government is the largest payer in healthcare, and plays a role in innovating payment models. CMMI is constantly testing new models, such as the recent ACO REACH. Keith sees the government as leading the way in pushing providers into value-based care models.The Cost of Standby. Healthcare operates on slim margins. A problem with this financing is that ER’s and ambulatory services are needed 24/7, but few want to pay the standby costs of having those services always available.  Relevant Links: Learn more about Keith Pitts

On this Wednesday's #TheShot of #DigitalHealth Therapy, Jim Joyce needed an intervention as HealthBeacon lost to a potato (you have to watch to find out) so we had the pleasure of chatting with Tina Tan, Executive Editor FirstWord HealthTech. Tina has been a writer and editor for the last two decades so she shares with us: ✏️ How to craft a story ✏️ Her non-passion of health policy ✏️ "No-sh$% factor" ✏️ NHS #digitalhealth adoption ✏️ oh and.... how to "pitch" to journalists Fun mentions as always: HealthXL Martin Kelly Chandana Fitzgerald Antonio Estrella Tim Kelsey NHSX UCL Shaine Borukhovich

Dr. David Klonoff and Dr. David Kerr are authors of a recent study that introduces a new practical metric, the glycemic risk index. They join the Huddle to talk about the practicalities of this emerging metric and share how it can be used by clinicians to quickly assess a person’s glycemic risk. It’s a fascinating conversation that will leave you with a tool to easier leverage CGM-generated data and produce improved health outcomes for your patients. ResourcesKlonoff, David C., et al. “A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.” Journal of Diabetes Science and Technology, Mar. 2022, doi:10.1177/19322968221085273GRI web-based calculator: https://www.diabetestechnology.org/gri/GRI Excel File to calculate multiple tracings: https://www.diabetestechnology.org/gri/gri-calculator.xlsx?ver=2Diabetes Digital Health book:  https://www.elsevier.com/books/diabetes-digital-health/klonoff/978-0-12-817485-2Diabetes Digital Health and Telehealth book: https://www.elsevier.com/books/diabetes-digital-health-and-telehealth/klonoff/978-0-323-90557-2

Listen to this episode as we sat down with the speakers at AusMedTech 22 making rounds of conversations surrounding healthcare and medtech related topics such as Australian manufacturing and global expansion , implications of cyber security, the diagnostic landscape post covid 19, building an appropriate board, and much more.

Meet Leslie Meehan:Leslie Meehan is the Deputy Commissioner for Population Health at the Tennessee Department of Health. Previously, she was the Director for the Office of Primary Prevention at the Tennessee Department of Health. She also served as the Director of Healthy Communities at the Nashville Area Metropolitan Planning Organization. She received a bachelor’s from Emory University and a master’s in public administration from Tennessee State University.  Key Insights:Leslie Meehan discusses top public health issues and new approaches to solve them.  Lessons from COVID-19. The pandemic can provide a vision for how public health challenges can be addressed in the future. Public-private partnerships and cross-sector collaboration could help us beat not just infectious diseases, but chronic diseases as well. Top Issue in Tennessee. The top two issues are housing and childcare. Both have become increasingly expensive due to limited supply, which was further exacerbated by the pandemic. The next biggest issues are transportation access and food systems. How You Show Up Matters. It’s important to listen and learn the problem, system, and players. First impressions are vital, especially when trying to influence decision-making outside of your field. It’s not just what you know, but also how you communicate. This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story and is the President and CEO of Dartmouth Health. Relevant Links:Learn more about Leslie MeehanCheck out her publications 

Healthcare is uniquely positioned to transform the healthcare consumer experience. There are so many advantages in healthcare – they have more data on patients than other industries have on their customers. They have an opportunity to interact with them in meaningful ways, and there is a huge opportunity to engage patients along the entire journey. Even within this highly regulated industry, there are a lot of opportunities that other industries don’t have. Join Heather Geisler, Chief Marketing Officer at Henry Ford Health System, and host Chris Hemphill as they explore the intersection of the consumer journey, branding, and the patient experience. This conversation is brought to you by Actium Health in partnership with the Forum for Healthcare Strategists.  Hosted on Acast. See acast.com/privacy for more information.

In this episode, Bobby Samuel, Vice President of Engineering at Anthem AI, talks about the organization's answer to financing the vision of orthopedic digital health through innovation, moving healthcare from reactive to preventative and proactive care.  When patients go from one physician to another specialist or hospital, oftentimes, their data must be collected on-site once again; This is why 52% of US health systems executives believe that data sharing or information sharing is the technology with the most impactful and positive outcome on patient experiences. At Anthem AI, they combine clinical data, like observations, labs, and diagnoses, as well as relevant social data with medical technology, machine learning, and AI to analyze data and deliver seamless experiences for patients and the whole community around healthcare. Bobby explains how this innovation moves healthcare towards connections and relationships to enhance the human experience. The vision of orthopedic digital health is funded by a wide range of companies that go from startups to established organizations to reduce the cost of care. Anthem has a member app called Sydney that uses AI machine learning to anticipate the member's needs; and a system called Health OS that connects clinicians to EMRs, with interfaces that strive to be delightful for either end and look to set the context of the experience.  Listen to Bobby talk about Anthem AI pulling data together and using technology to help people live the best and healthiest life possible, something that gets them and the vision of digital health funded!

Meet Carol Gallagher, Pharm.D.: Carol Gallagher, Pharm.D. is a Venture Partner at New Enterprise Associates. Previously, she was the  CEO of Calistoga Pharmaceuticals, and President and CEO of Metastatix. Dr. Gallagher currently  serves on the Board of Directors at Atara Biotherapeutics, Chromacode, PIONYR Biotherapeutics,  QPEX BioPharma, Recludix, Slope.io, TREX, and Turning Point Therapeutics, and is a Trustee for the  Salk Institute. She received a Doctor of Pharmacy from the University of Kentucky.Key Insights: Carol Gallagher, Pharm.D. explores the progression of her career through the pharmaceutical  industry and as a founder, CEO, and investor. • Complement Founders. Dr. Gallagher’s co-founder had a scientific background with immune system cancers, whereas she had experience with clinical trials and patient application related to B cell and other immunological disease. Founding a company is a team sport and building a complementary team is fundamental to success.• Self-Assessment. For all leaders, it’s important to have an honest self-assessment. Carol cites that the best CEOs are introspective. They understand their limitations and are also able to recruit the right team to fill those gaps.• Investment Philosophy. Innovators love to think about big changes, but sometimes incremental is good. When investing, Dr. Gallagher considers if the innovation can occur within the 3–5-year investment timeframe.This episode is hosted by Rick Lemoine, M.D. He is a member of the Advisory Council for Day Zero and is the Chief Medical Information Officer for Sharp HealthCare. Relevant Links:o Learn more about Carol Gallagher, Pharm.D.o Read “Salk Institute welcomes biopharmaceutical executive Carol Gallagher as new  trustee” 

In this episode, we talk with Melanie Cristol about satisfying, safe oral sex for women. Melanie Cristol is a peer sex educator and founder of MyLorals, a sexual wellness brand that makes latex undies for oral sex protection.  MyLorals are the first FDA-cleared underwear item on the market. These wearable, hassle-free alternatives to dental dams allow people of all genders to experience oral pleasure while minimizing the risk of STIs.  Melanie shares her story about creating wearable sexual wellness products, and how latex undies encourage protection, pleasure, and comfort— especially for people with vulvas. She talks about ways to bring up safer oral sex in the bedroom, and what it’s like to advertise a sex product online. Discussed in this episode: The story of how MyLorals was created The many benefits of oral sex for women  All the ways latex underwear can be used for sexual enjoyment and protection  Different types of safe sex products that exist today   The difference between FDA approval vs FDA clearance for sex products Challenges and solutions when advertising sexual wellness products online Ways to introduce Lorals into the bedroom  Benefits of Lorals compared to other oral sex protection tools “I truly believe oral sex can increase people’s moods, their self-esteem, and their happiness. Oral sex is 3x more likely to lead a woman to have an orgasm. To me, that’s an amazing thing.” - Melanie Cristol  Related to this episode: MyLorals.com MyLorals on Instagram: @mylorals Interview with Dr. Rachel Rubin: Women’s Orgasms Q&A Interview with Dr. Cat Meyer: Become Your Own Pleasure Activist Women and Orgasms: Questions, Myths, and Facts More Episodes on Sexual Health and Pleasure If you want to support our women’s health podcast, leave a review for Fempower Health on iTunes or Spotify. Spread the awareness and share this episode with someone you know! Support and connect with our women’s health community: Subscribe to the Fempower Health Podcast for new episodes every Tuesday Visit us online at www.fempower-health.com  Sign up for our weekly newsletter for the latest announcements, news, and research Follow us on Instagram, Facebook, and Twitter Email us for inquiries & outreach: [email protected]   **The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.** **Contains affiliate links and I will be compensated if you make a purchase after clicking on my links**

In this episode I speak with Seth Feurstein, Founder and CEO of Oui therapeutics, a digital therapeutic company that recently came out of stealth. In their own words: Oui is purpose built to tackle suicide and other challenging health care problems. In this episode, we cover: The background and funding journey to creating Oui Exisiting options for suicide prevention What is the patient experience on a digital therapeutic for suicide Approaching to the FDA with a DTx for sucicide prevention Commercializing DTx and scaling the company Guest Links and Resources: Connect with Seth Feurstein on LinkedIn | Twitter Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Derek Sham is an engineer turned general manager with successful PE-backed exit in 2016 of a urology diagnostic company- launched 8+ medical devices in urology, gynecology, gastroenterology and cardiology. Inspired to launch Cosm by a health episode with his grandmother. Cosm Medical is creating Personal Pelvic Health – a digital gynecology platform to personalize care for women affected by pelvic floor disorders such as pelvic organ prolapse and incontinence. Using emergent ultrasound, artificial intelligence and 3D printing, Gynethotics will personalize pelvic health devices so more women can live and age with dignity and grace.https://www.linkedin.com/in/derek-sham-87b1b114/www.cosm.care Podcast Link: https://link.chtbl.com/FemTechFocusSocial HandlesLinkedin: @FemTech Focus @Brittany BarretoTwitter: @Femtech_Focus @DrBrittBInstagram: @FemTechFocus @DrBrittanyBarretoFacebook: @FemTech Focus @Dr. Brittany BarretoFemTech Focus Bio:FemTech Focus is a 501c3 non-profit organization founded to bring awareness externally and internally for the FemTech industry and to empower the key stakeholders including entrepreneurs, investors, physicians, governments, and biopharma with resources and research to elevate women’s health and wellness globally. Subscribe and Donate: www.femtechfocus.orgFemTech Focus Podcast Description:The FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings women's health experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products that are improving women, female, and girl's health and wellness, collectively known as FemTech. The podcast gives the host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness. 

Did you know that viewing medical imaging can now be conveniently accessed by patients and clinicians in a single platform? This episode tackles the importance of having medical imaging on one platform and having an extended multi-disciplinary team. You’ll also get useful advice on taking the first step toward change, particularly in the most common issues that arise in the workplace every day.

Adam Odessky, CEO and co-founder of Sensely, discusses why engagement matters for individual patients and systems as a whole, how text to speech technology has advanced in recent years, opening up additional opportunities for virtual patient engagement, and what it meant to him and his team for Sensely to be patients’ primary point of contact following a diagnosis with COVID-19.

Episode Overview: In today’s life sciences environment, developing and approving new drugs can take upwards of twelve to 15 years. One significant reason for these arduous processes and timelines is the lack of automation and artificial intelligence integration. Our next guest and his company are poised to change the game! Emmanuel Walckenaer, CEO of Yseop, joins us to discuss his journey of becoming the CEO and how his company specializes in artificial intelligence and natural language processing to help pharmaceutical companies adopt modern technology solutions and bring their life-saving therapeutics to market faster. Join us to learn how Emmanuel and Yseop team free time and money in the life sciences space with their company’s intelligent automation. Let’s go! Episode Highlights: Emmanuel's journey on becoming the CEO of Yseop How Yseop was pulled into the pharmaceutical industry with one phone call What is CSR, its importance to healthcare, and how Yseop is automating it Emmanuales’s vision of AI and automation in the years to come About our Guest: Emmanuel joined Yseop as CEO in 2017, leading the company’s growth and vision to bring the benefits of automation and NLG to enterprise companies globally. He brings over 25 years of international experience in high-tech service and business development. Emmanuel joined Yseop in 2017 from Sierra Wireless, where he was General Manager and Senior Vice President of the Cloud and Connectivity Services business unit. He led the growth of this unit across Europe and North America through strategic acquisitions and the development of a bespoke cloud and connectivity offering for the expanding Internet of Things (IOT) market. Before joining Sierra Wireless, Emmanuel was Senior Vice President at Gemalto where he was responsible for the development of global Telecom business services. He had previously held various positions with Esso across IT and business development. Links Supporting This Episode: Yseop website: https://www.yseop.com/ (CLICK HERE) Emmanuel Walckenaer LinkedIn page: https://www.linkedin.com/in/emmanuelwalckenaer/ (CLICK HERE) Emmanuel Walckenaer Twitter page: https://twitter.com/EWalckenaer (CLICK HERE) Clubhouse handle: @mikebiselli Mike Biselli LinkedIn page: https://www.linkedin.com/in/mikebiselli (CLICK HERE) Mike Biselli Twitter page: https://twitter.com/mikebiselli (CLICK HERE) Visit our website: https://www.passionatepioneers.com/ (CLICK HERE) Subscribe to newsletter: https://forms.gle/PLdcj7ujAGEtunsj6 (CLICK HERE) Guest nomination form: https://docs.google.com/forms/d/e/1FAIpQLScqk_H_a79gCRsBLynkGp7JbdtFRWynTvPVV9ntOdEpExjQIQ/viewform (CLICK HERE)